Long term observations in a patient with pseudohypoaldosteronism
Related Experiment Video
Updated: Aug 19, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
R J Hogg1, J F Marks, D Marver
1Department of Pediatrics, Baylor University Medical Center, Dallas, TX 75246.
Insights
Severe pseudohypoaldosteronism (PHA) requires strict dietary management, including low potassium and high sodium intake, to achieve normal growth. This case highlights successful long-term management of a pediatric patient with persistent PHA.
Area of Science:
- Pediatric Endocrinology
- Nephrology
- Metabolic Disorders
Background:
- Pseudohypoaldosteronism (PHA) is a rare condition characterized by aldosterone resistance.
- Severe PHA in infants presents with significant electrolyte imbalances, including hyponatremia and hyperkalemia.
Observation:
- A patient with severe PHA, diagnosed at 10 days old, experienced life-threatening complications including cardiopulmonary arrest after a gastrointestinal illness.
- Despite persistent severe PHA, the patient achieved normal growth (95th percentile for height and weight) by age 12.5 years.
- Management involved a specialized low-potassium formula and substantial salt supplementation.
Findings:
- Serial studies revealed normal aldosterone binding, suppressible renin and aldosterone levels, and normal proximal tubule function.
- Increased prostaglandin excretion was noted, but inhibition with indomethacin provided no benefit.
- Impaired distal tubule function was evident during water diuresis.
Implications:
- Strict dietary manipulation, specifically low potassium and high sodium intake, is crucial for managing severe PHA and achieving normal growth.
- This case underscores the possibility of successful long-term management and normal development in pediatric patients with persistent PHA.
- Further research into the specific mechanisms of PHA and potential therapeutic targets, such as prostaglandin pathways, is warranted.
Abstract:
This paper describes a patient with severe pseudohypoaldosteronism (PHA) for over 12 years. The patient presented at 10 days of age with a serum sodium of 118 mEq/l and potassium of 12 mEq/l. After failing to maintain normal fluid and electrolyte status with standard therapy, including maximal mineralocorticoid stimulation, he was given a special formula containing minimal potassium plus salt supplements which normalized his electrolyte status. However, when he was 4.5 years of age, an acute gastrointestinal illness led to severe volume depletion, hyperkalemia, and cardiopulmonary arrest. This resulted in significant neurological impairment. At 12.5 years of age, the patient continues to require massive sodium supplements and his diet contains less than 0.5 mEq/kg potassium daily; his height and weight are at the 95th percentile, thus demonstrating that normal growth may be achieved with strict dietary manipulation in a patient with persistent, severe PHA. Serial studies to further define the lesion in this patient have demonstrated: (1) normal binding of aldosterone to aldosterone binding globulin (5.1% bound); (2) normal mineralocorticoid "activity"; (2) suppressible renin and aldosterone levels; (4) increased prostaglandin excretion (3.15 micrograms/g creatinine); (5) lack of benefit of prostaglandin inhibition with indomethacin; (6) normal proximal tubule function (CNa + CH2O = 18.0 ml/100 ml glomerular filtration rate; (7) impaired distal tubule function (CH2O/CNa + CH2O = 79.8%) during water diuresis.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure VI: Adjunct Therapies
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

